CEO Today Business Women Awards 2023 SWEDEN ABOUT SANA Sana Alajmovic is Co-Founder and Chief Executive Officer of Sigrid Therapeutics AB, with successful experience in commercializing research and discovery by establishing partnerships with global top tier biopharmaceutical actors. Sana Alajmovic has diverse experience in business development and management within the life science industry. Her previous positions include Head of Business Development for Drug Delivery at Nanologica, Business Development Manager at venture capital firm Serendipity Innovations Group and Project Manager for the SwedishAmerican Life Science Summit. Before joining the life science industry, Sana was Managing Director for the venture capital firm Curitas within the private equity group Procuritas, Operations Manager for the charity foundation Chelha and Assistant Events & Marketing Manager at the Swedish-American Chamber of Commerce in New York. SIGRID THERAPEUTICS AB Sigrid Therapeutics is a clinical-stage biotechnology company pioneering a new class of therapies to prevent and treat lifestyle diseases. Sigrid, a female Viking name meaning beautiful victory, was chosen to reflect the ground-breaking potential of our technology and the team’s commitment to advancing novel solutions for the prevention and treatment of our modern day chronic lifestyle diseases. CEO Sigrid Therapeutics AB SANA ALAJMOVIC
RkJQdWJsaXNoZXIy Mjk3Mzkz